Skip to main content

Table 3 Response to subsequent platinum-based chemotherapy

From: Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients

Response

n

%

Complete response

5

14.3

Partial response

18

51.4

Stable disease

8

22.9

Progressive diesase

4

11.4

Total

35

 
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us